Zofran Birth Defect Lawsuits
Zofran is a medication used to treat nausea and is often used for cancer
patients receiving treatment, or people who become sick following surgery.
Sadly, it is also sometimes prescribed to pregnant women to treat morning
sickness although it is unsafe for them to take it.
GlaxoSmithKline is the maker of Zofran and was fully aware of the risks
associated with taking it while pregnant. Tragically, the pharmaceutical
companies ignored warnings and research outcomes and pushed Zofran sales
to physicians and their patients. Now, many families are suing GSK for
negligence and failure to warn.
Zofran has been tested on animals and has been shown to reach past the
placental barrier. In addition, the FDA has not approved Zofran for safe
use during pregnancy, but GSK pushed the drug anyway. Zofran use during
the first trimester of pregnancy is linked to severe birth defects, including:
- cleft lip,
- cleft palate,
- and heart defects.
Families of children harmed by Zofran can seek compensation through a Zofran
lawsuit. Simply pick up the phone and
contact Meyerkord & Meyerkord, LLC to learn more about your rights.
Facts & Statistics: What You Should Know About Zofran & Pregnancy
In 2013, Danish medical researchers studied hundreds of thousands of prescribing
records in conjunction with births. It was found that women who took Zofran
during their first trimesters were 22% more likely to have babies with
a septal defect.
Furthermore, these women were also 41% more likely to have a child with
atrioventricular septal defects as well. Likewise, from 1997-2010 a second
study indicated that women who had taken Zofran during the first trimester
were more likely to have babies with congenital heart defects. In conclusion,
moms who took Zofran while pregnant were two to four times more likely
to have a baby with a defect.
Lawsuits Against Zofran Manufacturer, GlaxoSmithKline
Several lawsuits against GlaxoSmithKline (GSK), the makers of Zofran, are
coming forward. All lawsuits are alleging that when Zofran is taken during
the first trimester of pregnancy, babies are being born with severe birth
defects. Such defects include cleft lip, cleft palate, stillbirth, kidney
malformation, and congenital defects as well.
The plaintiffs allege that the drug maker failed to appropriately conduct
safety testing on the medication before marketing it to physicians. The
FDA did approve Zofran for use in cancer patients in 1991, but did not
approve it as safe for use during pregnancy. Unfortunately, GSK continued
to market and promote “off-label” versions of Zofran as a
safe and effective treatment for morning sickness in pregnant patients.
- In 2012, GSK was found guilty of charges relating to the following:
- They promoted Zofran for conditions other than it was approved for by the FDA
- They made false representation about the drug’s safety
- They paid and offered illegal remuneration to physicians to encourage Zofran
By 2000, GSK has received over 32 reports of birth defects associated with
Zofran use while pregnant. In 2006, a research study demonstrated that
Zofran reaches past the placental barrier into the fetus when taken during
the first trimester of pregnancy. Then, in 2014 results from studies again
showed that Zofran taken in the early stages of pregnancy gives the baby
increased risk of having heart defects.
Ready to Speak With a Lawyer? We’ll Review Your Case for Free.
At Meyerkord & Meyerkord, we understand that your child’s wellbeing
is your top priority, and should be represented as such. We are currently
representing Zofran cases, and if this drug harmed your child, we can
help. Please call our skilled
St. Louis personal injury attorneys today for a free consultation.